Results 141 to 150 of about 56,212,873 (163)

[Type 2 amiodarone-induced thyrotoxicosis: efficacy of glucocorticoid therapy, a retrospective analysis]. [PDF]

Probl Endokrinol (Mosk)
Ermolaeva AS, Fadeev VV.
europepmc   +1 more source

[The history of the pharmacotherapy of obesity]. [PDF]

Probl Endokrinol (Mosk)
Berkovskaya MA, Gurova OY, Surkova EV, Fadeev VV.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera, Hagop M Kantarjian, Victoria S Blinder   +2 more
exaly  

American Cancer Society Head and Neck Cancer Survivorship Care Guideline

Ca-A Cancer Journal for Clinicians, 2016
Nader Sadeghi, Katherine A Hutcheson, Gary H Lyman   +2 more
exaly  

Spirituality and religion in oncology

Ca-A Cancer Journal for Clinicians, 2013
John R Peteet
exaly